Round brings total capital raised to over $240M.

Funding Brings Total Raised to $47.5M as Demand Grows for Better Infrastructure to Support Biopharma

Submission includes a concurrent CLIA Waiver by Application for use of the test on the Co-Dx PCR Pro® instrument in decentralized point-of-care settings.

A company still awaiting its first FDA clearance just structured a capital raise around the urgency of that wait. On July 30, 2026, Co-Diagnostics, Inc. entered into a warrant inducement agreement with existing warrant holders, convincing them to exercise warrants early in exchange for new warrants at revised terms. The transaction is straightforward on its […]

ARUP Laboratories observed Cyclospora positivity rates increase from very low levels to unprecedented levels within a short period of time.

Investment will support commercialization of GPX and ULTRA Embolic Devices and development of IMPASS neurovascular platform.

Canyon Labs strengthens its commitment to medical device manufacturers with strategic, direct-access leadership investments.

Southern Metrics is led by Chris Lyons, its Chief Executive Officer, an experienced medical technology executive and strategic advisor who has served on the SINTX Board of Directors since April 2025.